Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

244
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
244

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High-Risk Individuals in Australia.

The Medical journal of Australia·2026
Same author

Diagnostic Delays in Thoracic Cancer Care: A Data-Linkage, Cohort Study between Primary Care, Hospital, and Registry Data.

Health data science·2026
Same author

Timeliness of Care and Treatment Patterns for Pancreatic Cancer in Victoria, Australia: Comparison With Optimal Care Pathways Targets.

ANZ journal of surgery·2026
Same author

Clinical Decision Support Tool for Early Pancreatic Cancer Detection in Primary Care: Simulation Study.

JMIR formative research·2026
Same author

Decision support tools for pancreatic cancer detection: external validation in Australian primary care - a retrospective cohort study.

The British journal of general practice : the journal of the Royal College of General Practitioners·2026
Same author

Time to diagnosis and treatment in lymphoma and implications for health-related outcomes: a systematic review.

Leukemia & lymphoma·2025

相关实验视频

Updated: Jun 17, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.1K

在澳大利亚一般实践中实施药物基因组测试:一项探索性定性研究.

Emma Ewasiuk1, Jon Emery2,3, Gabrielle Reid1

  • 1Department of Paediatrics, University of Melbourne, Melbourne, 3010, Australia.

Pharmacogenomics
|August 7, 2024
PubMed
概括

澳大利亚的全科医生看到了药基因组测试的潜力,但面临着缺乏教育和指导方针等障碍. 成功实施需要更多的证据,标准化报告和更好的财务可用性.

关键词:
实施研究研究的综合框架.一般的做法一般的做法.基因检测 基因检测是指基因检测.实施实施实施实施实施.个性化的基因组医学药物基因组学 药物基因组学

更多相关视频

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.0K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

652

相关实验视频

Last Updated: Jun 17, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.1K
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.0K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

652

科学领域:

  • 药物基因组学 药物基因组学
  • 一般的做法一般的做法
  • 实施科学 实施科学

背景情况:

  • 药基因组测试提供了个性化医学的潜力.
  • 融入澳大利亚的全科医院需要了解临床医生的观点.

研究的目的:

  • 探讨一般医生 (GPs) 关于在澳大利亚一般实践中实施药物基因组测试的观点.

主要方法:

  • 与九名澳大利亚全科医生的半结构面试.
  • 对面试数据进行主题分析.
  • 将主题映射到实施研究综合框架中.

主要成果:

  • 确定了关键障碍:缺乏知识,教育,标准化报告,国家指导方针和财务限制.
  • 促进者包括积极的接触,同行影响,跨学科的合作,和感知到的临床效用.
  • 目前的吸收量很小,但全科医生对临床应用持积极看法.

结论:

  • 建议包括传播临床证据,制定国家指导方针和标准化报告.
  • 正式教育和增加财务可访问性对于成功实施至关重要.
  • 解决已识别的障碍和利用促进者可以促进药物基因组测试在一般实践中的采用.